Biotech drugmaker CollaGenex Pharmaceuticals Inc. said Tuesday that its fourth-quarter loss narrowed with sales of its recently approved product Oracea.
From: biz.yahoo.com
CollaGenex 4Q Loss Narrows on Oracea
Posted by Ruslan Abuzant at 7:43 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment